コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 l systems and (2) the calcium sensitivity of actomyosin ATPase.
2 lays a major role in the changed kinetics of actomyosin ATPase.
3 and an increased calcium sensitivity of the actomyosin ATPase.
4 actin and the V(max) and K(m) parameters of actomyosin ATPase.
5 omyosin in a position on actin that inhibits actomyosin ATPase.
6 independently, TnI is capable of inhibiting actomyosin ATPase.
7 core sequence for CaD-induced inhibition of actomyosin ATPase.
8 en for full-length CaD) of inhibition of the actomyosin ATPase.
9 ibute to tropomyosin-dependent inhibition of actomyosin ATPase: a central segment [747-767 (690-710 i
10 aining HSSTnT1, -2, and -3 did not alter the actomyosin ATPase activation and inhibition in the prese
13 le EMD 57033 has been shown to stimulate the actomyosin ATPase activity and contractility of myofilam
14 oth D75Y and E59D are required to reduce the actomyosin ATPase activity and maximal force in muscle f
15 the actin-binding protein caldesmon inhibits actomyosin ATPase activity and might in this way take pa
16 ic cardiomyopathy-causing mutations in cTnI, actomyosin ATPase activity and skinned fiber studies wer
17 nT1 DCM mutations strongly decreased maximal actomyosin ATPase activity as compared with TnT1-WT.
18 e CaM-mediated reversal of the inhibition of actomyosin ATPase activity by CaD and for the functional
19 and flexibility of crossbridges may regulate actomyosin ATPase activity by modifying the kinetics of
20 r results suggest that a decrease in maximal actomyosin ATPase activity in conjunction with decreased
21 ere examined by monitoring the time-resolved actomyosin ATPase activity in COPD and non-COPD fibres t
22 sensitivity, while simultaneously measuring actomyosin ATPase activity in situ by a fluorimetric tec
23 ard smooth muscle caldesmon (CaD) to inhibit actomyosin ATPase activity is due mainly to an inhibitor
25 etter predictor of the calcium dependence of actomyosin ATPase activity than that of TnC or the Tn co
26 elin increases isometric force and decreases actomyosin ATPase activity thus increasing the economy o
27 Analysis of actin binding and inhibition of actomyosin ATPase activity using these mutants identifie
31 l isoforms) had a reduced ability to inhibit actomyosin ATPase activity when compared with cTnT3 (adu
32 ponent of the troponin complex that inhibits actomyosin ATPase activity, and Ca(2+) binding to the tr
33 dothelin-1 raised isometric force, decreased actomyosin ATPase activity, and decreased unloaded short
34 tivities of the thin filament, reconstituted actomyosin ATPase activity, and force generation in skin
35 s purified co-sediments with actin, inhibits actomyosin ATPase activity, and interacts with Ca2+/calm
37 e or release, sarcolemmal Na+/Ca2+ exchange, actomyosin ATPase activity, L-type Ca2+ channel current,
38 which inhibits tropomyosin's potentiation of actomyosin ATPase activity, moves tropomyosin in one dir
47 bfragment-2 portion of myosin, which reduces actomyosin ATPase activity; phosphorylation abolishes th
48 hift the distribution of crossbridges in the actomyosin ATPase (AMATPase) to increase the relative po
49 act as a tether still have an effect on the actomyosin ATPase and (b) as to why the myosin head posi
51 Phosphorylation at these sites inhibits the actomyosin ATPase and inhibits phosphorylation of S19 on
52 uce the activity of TnI in the inhibition of actomyosin ATPase and result in cardiac muscle malfuncti
53 17 is responsible for the weak inhibition of actomyosin ATPase and reveal that the inhibitory determi
55 domains of CaD involved in the regulation of actomyosin ATPase and the binding of actin, tropomyosin,
56 osin to assume a second position, initiating actomyosin ATPase and thus permitting contraction to pro
57 ient for tropomyosin-dependent inhibition of actomyosin ATPase; and two actin binding segments N-term
58 paring wild-type (WT) and mutant proteins in actomyosin ATPase assays and in troponin-replaced rabbit
62 onin-tropomyosin and therefore inhibition of actomyosin ATPase by caldesmon-tropomyosin and by tropon
63 that of troponin and therefore inhibition of actomyosin ATPase by calponin and troponin cannot be str
64 ges may help explain how force modulates the actomyosin ATPase cycle and thus the physiology and ener
65 ent kinetic data show that most steps of the actomyosin ATPase cycle are slowed down compared with ot
67 ng-to-weak structural transitions during the actomyosin ATPase cycle in an isoform-dependent manner,
68 ng that myosin Vc spends the majority of the actomyosin ATPase cycle in weak actin-binding states, un
69 n is qualitatively predicted by a simplified actomyosin ATPase cycle where a pre-phosphate release, f
70 d an increase in the maximum velocity of the actomyosin ATPase cycle, and our transient-kinetics expe
78 ic constants for each step in the myosin and actomyosin ATPase cycles of recombinant wild-type S1 and
83 r calmodulin (CaM) binding and actin-binding/actomyosin ATPase inhibition are present in the region b
86 oes the heated CaD; its inhibitory action on actomyosin ATPase is reversed by a much lesser amount of
87 D89A and alpha h89A activated the regulated actomyosin ATPase poorly in the presence of Ca2+ (24 +/-
89 e of the fundamental mechanochemistry of the actomyosin ATPase reaction under a minimal load and serv
90 gh most of the mutants were able to activate actomyosin ATPase similarly to wild-type cTnI, L144Q had
94 a significant increase in the activation of actomyosin ATPase with either CTnI or SSTnI, whereas HCT
95 assayed for actin binding, regulation of the actomyosin ATPase with troponin, cooperative myosin S1-i
96 s the mutant increased the activation of the actomyosin ATPase without affecting the inhibitory quali
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。